Home › Funds › PFM Health Sciences, LP › LNTH
PFM Health Sciences, LP position in LNTH
LANTHEUS HLDGS INC COM · Health Care
PFM Health Sciences, LP reported holding 146,403 shares of LNTH (LANTHEUS HLDGS INC COM) in its Q2 2026 13F filing — a position valued at US$16.2M, representing 1.42% of its reported portfolio and ranking #22 among its reported holdings. PFM Health Sciences, LP has disclosed LNTH holdings in 2 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's LNTH position evolved
PFM Health Sciences, LP first disclosed a stake in LNTH in Q3 2023 at 372,761 shares (US$25.9M). Across 2 filings, PFM Health Sciences, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 146,403 shares valued at US$16.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 372.76K | $25.90M | New |
| Q2 2026 | 146.40K | $16.24M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LNTH and 13F data
LNTH (LANTHEUS HLDGS INC COM) is a Health Care company. 40 other funds we track also report a position in LNTH — the largest reported positions include Farallon Capital Management (US$619.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$619.4M), Carmignac Gestion (US$148.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LNTH
- Farallon Capital Management 5.58M sh · $619.43M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 5.58M sh · $619.43M · Q2 2026
- Carmignac Gestion 1.34M sh · $148.67M · Q2 2026
- REINHART PARTNERS, LLC. 1.21M sh · $120.22M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 753.00K sh · $83.54M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held LNTH?
PFM Health Sciences, LP has disclosed LNTH holdings in 2 of the last 12 reported quarters, going back to Q3 2023.
What is PFM Health Sciences, LP's current position in LNTH?
As of Q2 2026, PFM Health Sciences, LP holds 146.40K shares of LNTH (LANTHEUS HLDGS INC COM), valued at $16.24M, representing 1.42% of its reported portfolio and ranking #22.
Has PFM Health Sciences, LP been buying or selling LNTH?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP newly opened its position in LNTH.
Which other funds hold LNTH?
Other major institutional holders of LNTH include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Carmignac Gestion, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.